Safe Renal Function In Long Term Heart Transplanted Patients
Status:
Unknown status
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to verify whether the reduction of cyclosporine dosages
associated with Everolimus administration may improve renal function as compared to patients
maintained on standard immunosuppressive therapy
Phase:
Phase 4
Details
Lead Sponsor:
A.O. Ospedale Papa Giovanni XXIII
Collaborator:
Mario Negri Institute for Pharmacological Research